Just another lie. You'll never go away. More likely, you'll create a THIRD alias and have a FUD circle-jerk.
If you had something of substance to say here, fine, we could debate, but you don't. You just complain because a penny stock with no news doesn't skyrocket.
Let's get this straight -- you claim that "real buyers" could drive this stock from 15 cents to $5 with no news. 15 cents to $5. Over 3000% increase. On no news.
You've seen this happen before in the stock market, EVER? Name the ticker. Remember: there can't have been any news.
I've seen the occasional rare 3000% increase, but only on pennystocks that were beaten down and got unexpected news. With GTHP the news is expected and it's not beaten down at 15 cents - -that's the resulting price from the last R/S.
You lost money on GTHP after that last FDA rejection and resulting death spiral R/S, and it made you feel bad about yourself. You're holding a grudge and it makes you feel a little bit better about yourself to try and make others feel bad today. Well, news flash, I lost money on that last FDA rejection, but I didn't feel bad about myself then and I don't feel bad now. That's the pennystock biotech game we're playing: high risk, high rewards.
I sold right after the FDA rejection because that's how to play this game -- take your loss and move on. I stayed away when they sank into death spiral financing, but somehow Cartwright chased the toxic lender moneychangers out of the temple and pulled the company out of the death spiral. Now THERE's a thing I've never seen before. So I'm back in, and I expect to make money on this stock, although $5 per share is ludicrous even with PMA approval.
You couldn't handle the risk -- no shame in that. Not everyone can handle the risks of gambling on penny biotech. You should buy ETF's instead. And if you stop your mindless childish bashing of GTHP, you might actually get over your losses and start feeling better about yourself.
BTW, Auctus filed their annual Valentines' Day 13G. They hold more today than they held last year, even after they dumped their ill-gotten shares last June.
